Stockreport

Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026 [Yahoo! Finance]

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF LEXINGTON, Mass., April 21, 2026 BUSINESS WIRE Agenus Inc. (Nasdaq: AGEN) , a leader in immuno-oncology innovation, today announced that four abstracts highlighting bot [Read more]